Ledger.Open graph →
SEC Form D · Amendment · filed November 23, 2016

Ribon Therapeutics, Inc

Offering
$23.5M
Sold
$23.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Lexington, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jonathan M. Root · Lexington, MADirectorCameron M. Wheeler · Lexington, MADirectorVictoria M. Richon · Lexington, MAExec · DirectorLaurence Lasky · Lexington, MADirectorLarry A. Schwartz · BOULDER, CODirectorDeborah A. Gillotti · BOULDER, CODirectorCharles N. Corfield · BOULDER, CODirectorSteve A. Tran · BOULDER, COExec · DirectorJohn Garofalo · Concord, MADirectorStefan Kowski · London, United KingdomDirectorBastian Lueken · London, United KingdomDirectorStephen Peel · London, United KingdomExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗